Back to top

Image: Bigstock

ACM Research (ACMR) Soars: Stock Adds 9.4% in Session

Read MoreHide Full Article

ACM Research, Inc. (ACMR - Free Report) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company — as the stock is now down 36.7% in the past one-month time frame.

The company has seen two negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

ACM Research currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

 

 

A better-ranked stock in the Computer and Technology sector is Atomera Incorporated (ATOM - Free Report) , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


ACM Research, Inc. (ACMR) - free report >>

Atomera Incorporated (ATOM) - free report >>

Published in